Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, Lai JY, Zhou Y, Hawkins JJ, Bitzer M, Sampson MG, Thier M, Solier C, Duran-Pacheco GC, Duchateau-Nguyen G, Essioux L, Schott B, Formentini I, Magnone MC, Bobadilla M, Cohen CD, Bagnasco SM, Barisoni L, Lv J, Zhang H, Wang HY, Brosius FC, Gadegbeku CA, Kretzler M; ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium.

Sci Transl Med. 2015 Dec 2;7(316):316ra193. doi: 10.1126/scitranslmed.aac7071.

2.

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia.

Palermo G, Maisel D, Barrett M, Smith H, Duchateau-Nguyen G, Nguyen T, Yeh RF, Dufour A, Robak T, Dornan D, Weisser M; REACH investigators.

Blood Cancer J. 2015 Oct 2;5:e353. doi: 10.1038/bcj.2015.82.

3.

Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

Cotillard A, Poitou C, Duchâteau-Nguyen G, Aron-Wisnewsky J, Bouillot JL, Schindler T, Clément K.

Obes Surg. 2015 Jul;25(7):1128-32. doi: 10.1007/s11695-014-1511-8.

4.

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia.

Weisser M, Yeh RF, Duchateau-Nguyen G, Palermo G, Nguyen TQ, Shi X, Stinson SY, Yu N, Dufour A, Robak T, Salogub GN, Dmoszynska A, Solal-Celigny P, Warzocha K, Loscertales J, Catalano J, Larratt L, Rossiev VA, Bence-Bruckler I, Geisler CH, Montillo M, Fischer K, Fink AM, Hallek M, Bloehdorn J, Busch R, Benner A, Döhner H, Valente N, Wenger MK, Stilgenbauer S, Dornan D.

Blood. 2014 Jul 17;124(3):420-5. doi: 10.1182/blood-2013-12-538975. Epub 2014 Jun 10.

5.

Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4.

Kiu Weber CI, Duchateau-Nguyen G, Solier C, Schell-Steven A, Hermosilla R, Nogoceke E, Block G.

Clin Kidney J. 2014 Apr;7(2):167-173. Epub 2014 Mar 9.

6.

Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients.

Dufour A, Palermo G, Zellmeier E, Mellert G, Duchateau-Nguyen G, Schneider S, Benthaus T, Kakadia PM, Spiekermann K, Hiddemann W, Braess J, Truong S, Patten N, Wu L, Lohmann S, Dornan D, GuhaThakurta D, Yeh RF, Salogub G, Solal-Celigny P, Dmoszynska A, Robak T, Montillo M, Catalano J, Geisler CH, Weisser M, Bohlander SK.

Blood. 2013 May 2;121(18):3650-7. doi: 10.1182/blood-2012-10-458695. Epub 2013 Mar 22.

7.

Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell lines.

Augustin A, Lamerz J, Meistermann H, Golling S, Scheiblich S, Hermann JC, Duchateau-Nguyen G, Tzouros M, Avila DW, Langen H, Essioux L, Klughammer B.

Mol Cancer Ther. 2013 Apr;12(4):520-9. doi: 10.1158/1535-7163.MCT-12-0880. Epub 2013 Jan 31.

8.

Effect of FCGR2A and FCGR3A variants on CLL outcome.

Dornan D, Spleiss O, Yeh RF, Duchateau-Nguyen G, Dufour A, Zhi J, Robak T, Moiseev SI, Dmoszynska A, Solal-Celigny P, Warzocha K, Loscertales J, Catalano J, Afanasiev BV, Larratt L, Rossiev VA, Bence-Bruckler I, Geisler CH, Montillo M, Wenger MK, Weisser M.

Blood. 2010 Nov 18;116(20):4212-22. doi: 10.1182/blood-2010-03-272765. Epub 2010 Aug 12.

9.

A longitudinal study of gene expression in healthy individuals.

Karlovich C, Duchateau-Nguyen G, Johnson A, McLoughlin P, Navarro M, Fleurbaey C, Steiner L, Tessier M, Nguyen T, Wilhelm-Seiler M, Caulfield JP.

BMC Med Genomics. 2009 Jun 7;2:33. doi: 10.1186/1755-8794-2-33.

10.

A pairwise alignment algorithm which favors clusters of blocks.

Nédélec E, Moncion T, Gassiat E, Bossard B, Duchateau-Nguyen G, Denise A, Termier M.

J Comput Biol. 2005;12(1):33-47.

PMID:
15725732
11.

Identification of stop codon readthrough genes in Saccharomyces cerevisiae.

Namy O, Duchateau-Nguyen G, Hatin I, Hermann-Le Denmat S, Termier M, Rousset JP.

Nucleic Acids Res. 2003 May 1;31(9):2289-96.

12.

Towards a computational model for -1 eukaryotic frameshifting sites.

Bekaert M, Bidou L, Denise A, Duchateau-Nguyen G, Forest JP, Froidevaux C, Hatin I, Rousset JP, Termier M.

Bioinformatics. 2003 Feb 12;19(3):327-35.

PMID:
12584117
13.

Translational readthrough of the PDE2 stop codon modulates cAMP levels in Saccharomyces cerevisiae.

Namy O, Duchateau-Nguyen G, Rousset JP.

Mol Microbiol. 2002 Feb;43(3):641-52.

14.

Genomic exploration of the hemiascomycetous yeasts: 21. Comparative functional classification of genes.

Gaillardin C, Duchateau-Nguyen G, Tekaia F, Llorente B, Casaregola S, Toffano-Nioche C, Aigle M, Artiguenave F, Blandin G, Bolotin-Fukuhara M, Bon E, Brottier P, de Montigny J, Dujon B, Durrens P, Lépingle A, Malpertuy A, Neuvéglise C, Ozier-Kalogéropoulos O, Potier S, Saurin W, Termier M, Wésolowski-Louvel M, Wincker P, Souciet J, Weissenbach J.

FEBS Lett. 2000 Dec 22;487(1):134-49.

15.

Genomic exploration of the hemiascomycetous yeasts: 11. Kluyveromyces lactis.

Bolotin-Fukuhara M, Toffano-Nioche C, Artiguenave F, Duchateau-Nguyen G, Lemaire M, Marmeisse R, Montrocher R, Robert C, Termier M, Wincker P, Wésolowski-Louvel M.

FEBS Lett. 2000 Dec 22;487(1):66-70.

Supplemental Content

Loading ...
Support Center